Skip to main navigation Skip to search Skip to main content

Advancing mitochondria as a therapeutic agent: Advancing mitochondria as a therapeutic Agent

  • Mito-Act Research Consortium
  • University of Alabama at Birmingham

Research output: Contribution to journalEditorial

7 Scopus citations

Abstract

This article intends to provide an update of the needs in the field working in the artificial mitochondrial transfer/transplant (AMT/T), and an overview of the highlights from the articles in the special issue “Advances of Mitochondria as a therapeutic agent”. In the last 4 decades, scientists developed innovative therapeutic applications based on the AMT/T, inspired by the natural transfer of mitochondria between cells to repair cellular damage or treat diseases. The clinical application of AMT has become the priority for the field involving the replacement or augmentation of healthy mitochondria in the harmed tissue, especially in the treatment of organ ischemia–reperfusion injury. However, we remark in our article that key questions remain to be answered such which one is the best isolation protocol, tissue or cell source for isolation, and others of great importance to move the field forward.

Original languageEnglish
Pages (from-to)33-35
Number of pages3
JournalMitochondrion
Volume69
DOIs
StatePublished - Mar 2023

Keywords

  • Humans
  • Mitochondria
  • Reperfusion Injury/therapy

Fingerprint

Dive into the research topics of 'Advancing mitochondria as a therapeutic agent: Advancing mitochondria as a therapeutic Agent'. Together they form a unique fingerprint.

Cite this